3653 results for «358»

Filter By

3653 results

Best companion's cases on imaging for calcified lesions

20 May 2025 – From EuroPCR 2025

Join this session to explore cutting-edge imaging-guided strategies for treating calcified coronary lesions. Featuring OCT guidance, CT density analysis, and innovative zero-contrast PCI approaches including lithotripsy, this session highlights novel and ultra-low contrast interventions tailored for complex calcified cases and kidney failure patients.

Best companion's cases on imaging for calcified lesions

CTO in special clinical scenarios

20 May 2025 – From EuroPCR 2025

This session focuses on the unique challenges of performing CTO interventions in special clinical scenarios, including critical donor artery stenosis, anomalous coronary origins post-TAVI, and complex multivessel disease with limited vascular access. Gain insights into tailored strategies such as retrograde approaches and management after arterial switch...

CTO in special clinical scenarios

Intracoronary imaging-guided MINOCA management

20 May 2025 – From EuroPCR 2025

This session addresses the nuanced role of intracoronary imaging in guiding the management of MINOCA patients. Explore interventions including interventional endarterectomy, cutting-balloon PCI for spontaneous coronary artery dissection, strategies for spastic vulnerable plaques, and unusual acute STEMI presentations.

Intracoronary imaging-guided MINOCA management

Treatment and prognostic stratification of ACS patients with cardiogenic shock

21 May 2025 – From EuroPCR 2025

This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.

Treatment and prognostic stratification of ACS patients with cardiogenic shock

Tough cases, smart imaging

20 May 2025 – From EuroPCR 2025

This session showcases challenging cardiovascular cases where smart imaging techniques guide diagnosis and intervention. Highlights include innovative soft balloon angiography in complex patients, anatomical-physiological ischemic mismatch analysis, IVUS-guided evaluation of rare SVG stenosis, and the power of perspective in imaging interpretation.

Tough cases, smart imaging

When multivessel disease is so complex

21 May 2025 – From EuroPCR 2025

Addressing the complexities of multivessel coronary disease, this session presents challenging cases including double chronic total occlusions and the emerging link between blood lipids and plaque formation. Learn strategic approaches to revascularization in NSTEMI and investigative insights into plaque biology.

When multivessel disease is so complex

When coronary angiography is not enough

20 May 2025 – From EuroPCR 2025

Dive into the complexities that arise when coronary angiography alone is insufficient. This session explores comprehensive physiology and imaging assessments in INOCA with ventricular fibrillation, repeat coronary events, acetylcholine testing for epicardial spasm, and invasive physiology to stratify angina therapy.

When coronary angiography is not enough

How to optimise radiation exposure in the cathlab

21 May 2025 – From EuroPCR 2025

Explore comprehensive strategies to optimise radiation exposure in the cathlab through innovative technologies and workflow improvements. This session covers the implementation of radiation protection cabins, insights from the ROBO-SIL registry on robotic PCI, use of protective drapes, the EggNest system, exoskeleton-based radiation protection suits, and comparative...

How to optimise radiation exposure in the cathlab

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!

29 Sep 2023

Global burden of Cardiovascular Disease

Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...

Vijay Kunadian

Author

Vijay Kunadian
World Heart Day 2023

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030

29 Aug 2021

Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.

Vijay Kunadian

Author

Vijay Kunadian
ESC Congress 2021 - Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
Didn’t find what you were looking for?